Latest News and Press Releases

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and Ibogaine...

NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank you for your continued support as we advance our mission to develop...

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the...

Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videosConference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring...

MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...

MIAMI, May 02, 2024 (GLOBE NEWSWIRE) --  Ibogaine by David Dardashti looks to revolutionize the field of ibogaine addiction treatment through its recent exploration of the effects of quantum physics...

MIAMI, April 26, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is taking proactive steps to prove the efficacy of ibogaine hydrochloride in improving inflammation levels in the body. ...

MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a prominent provider of natural and holistic remedies for substance abuse, has developed a novel algorithm to tackle the...

MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- The novel algorithm signifies a notable deviation from Suboxone, a frequently administered medication for treating opioid addiction, as it incorporates...